Search Results
152 items found for "cancer immune checkpoints"
- 📰 GPCR Weekly News, April 1 to 7, 2024
steatotic liver disease GPCRs in Oncology and Immunology Chemoattractant receptor signaling in humoral immunity
- All Aboard the GPCR Express: Your Weekly Update is here! Oct 14-20, 2024
Congrats to: Monserrat Avila-Zozaya , our incredible contributor, for her fantastic article on Profiling Immune
- 📰 GPCR Weekly News, June 3 to June 9, 2024
correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer
- 📰 GPCR Weekly News, May 22 to 28, 2023
intertwining roles of caveolin, oxytocin receptor, and the associated signalling pathways in prostate cancer
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
neurogenic properties GPCRs in Oncology and Immunology Chemoattractant receptor signaling in humoral immunity
- 📰 GPCR Weekly News, November 6 to November 12, 2023
November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GPCR signaling contributes to immune
- 📰 GPCR Weekly News, September 25 to October 1, 2023
protein-coupled receptors: A target for microbial metabolites and a mechanistic link to microbiome-immune-brain
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
for a number of inflammatory diseases including atherosclerosis, scleroderma, multiple sclerosis and cancer and efficiently advance a diversified portfolio of GPCR-targeted drug candidates for the treatment of cancer PROcisionXᵀᴹ discovery platform Structure-based validation of Orion’s approach Zheng, Y. et al. (2017) Immunity
- Dr. GPCR University registration is now open! Secure your spot now!
GPCRs in Oncology and Immunology Unveiling G-protein coupled receptors as potential targets for ovarian cancer
- 📰 GPCR Weekly News, April 3 to 9, 2023
GPCR Events, Meetings, and Webinars NEW AACR 2023 - American Association for Cancer Research (April 14
- 📰 GPCR Weekly News, March 20 to 26, 2023
kidney disease GPCRs in Oncology and Immunology Purinergic GPCR-integrin interactions drive pancreatic cancer
- 📰 GPCR Weekly News, September 18 to 24, 2023
protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
- 📰 GPCR Weekly News, August 28 to September 3, 2023
back again: the lysophosphatidic acid-CCN axis in signal transduction NPFF stimulates human ovarian cancer
- 📰 GPCR Weekly News, March 11 to 17, 2024
Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer
- 📰 GPCR Weekly News, July 31 to August 6, 2023
fibroblast heterogeneity in fibroblast-associated diseases Ultrasensitive dose-response for asbestos cancer
- 📰 GPCR Weekly News, February 26 to March 3, 2024
endocrinology and metabolism Reviews, GPCRs, and more Butyrate as a promising therapeutic target in cancer
- 📰 GPCR Weekly News, February 5 to 11, 2024
News Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer
- 📰 GPCR Weekly News, February 27 to March 5, 2023
GPCRs in Oncology and Immunology GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer
- Unlocking the Future of Medicine: Advancements in GPCR Research
Reviews, GPCRs, and more Lessons from the physiological role of guanosine in neurodegeneration and cancer
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Oncology and Immunology Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer
- 📰 GPCR Weekly News, December 18 to 31, 2023
Adhesion GPCRs Latrophilin, an adhesion GPCR with galactose-binding lectin domain involved in the innate immune
- 📰 GPCR Weekly News, February 20 to 26, 2023
Small-molecule targeting of GPCR-independent non-canonical G protein signaling inhibits cancer progression
- 📰 GPCR Weekly News, April 15 to 21, 2024
Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer
- Structural landscape of the Chemokine Receptor system
belong to a subfamily of G-protein-coupled receptors (GPCRs) and play a crucial role in inflammation and immune US28 evolved high constitutive activity to evade host immunity, whereas ACKR3 functions as a homeostatic
- 📰 GPCR Weekly News, July 1 to 7, 2024
targets for AUD: Insights from preclinical studies CB2 stimulation of adipose resident ILC2s orchestrates immune
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
significant challenge in drug development, particularly in the treatment of infectious diseases and cancer
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
in a mouse model of sciatic nerve injury GPCRs in Oncology and Immunology GPR37 promotes colorectal cancer
- 📰 GPCR Weekly News, February 12 to 18, 2024
infection Industry News InterAx Biotech's AI platform unlocks new drug designs for diabetes, obesity, and cancer